Key result
Elevated baseline blood pressure linked to ~70% higher risk of cognitive decline in older adults.
Why the study?
A rapid increase in cardiometabolic diseases in India may contribute to increased late-life cognitive impairment, but the longitudinal associations between baseline cardiometabolic risk factors and subsequent cognitive decline needed evaluation.
Do baseline cardiometabolic and inflammatory risk factors increase the risk of subsequent cognitive decline and mortality in older adults in India?
Cohort (n=1,554)
Yes
Do baseline cardiometabolic and inflammatory risk factors increase the risk of subsequent cognitive decline and mortality in older adults in India?
Modifiable cardiometabolic risk factors, including elevated blood pressure, HbA1c, and uric acid, are independently associated with cognitive decline and mortality in older adults in India, highlighting the need for targeted early management.
Answers are grounded in this paper and cite their sources.
Elevated BP was associated with cognitive decline in older Indian adults; extends limited evidence to this population but leaves causal inference open.
BACKGROUND: Rapid increase in cardiometabolic diseases in India may contribute to increased incidence of late-life cognitive impairment. This study focuses on associations between baseline cardiometabolic risk factors and subsequent decline in cognitive function among older adults in India, leveraging data from two waves (Wave 1: 2017-2020, Wave 2: 2022-2024) of the Longitudinal Aging Study in India-Diagnostic Assessment of Dementia (LASI-DAD). METHODS: Analysis included longitudinal data of 1554 study participants. A summary measure of different cognitive functional domains was used. Cognitive decline was defined as annual decline in cognitive score ≥ 0.05 times the standard deviation of the summary score. Cardiometabolic risk was characterized using cardiovascular, metabolic, and inflammatory biomarkers. Multivariate, multinomial logistic regression analysis was used to examine the associations between cardiometabolic risk and cognitive decline. RESULTS: At baseline, 71.7% of the sample had elevated homocysteine levels, 44.4% had elevated blood pressure, 23% had elevated glycosylated hemoglobin (HbA1c), and 6.7% had elevated uric acid levels. Between the two waves, 34.8% experienced significant cognitive decline, while 35.6% died. Multivariate multinomial logistic regression showed significant cognitive decline was associated with elevated blood pressure [odds ratio (OR): 1.7, 95% confidence interval (CI) 1.3-2.2], elevated HbA1c (OR: 1.1, 95% CI: 1.0-1.2), being overweight (OR: 1.4, 95% CI: 1.0-2.0), and elevated uric acid level (OR: 1.2, 95% CI: 1.0-1.3). Those with hypertension had 1.5 times higher odds of mortality (95% confidence interval: 1.2-2.0), while those with diabetes mellitus or elevated pro-brain natriuretic peptide had 1.2 times (95% CI: 1.1-1.4), and 1.8 times (95% CI: 1.1-1.4) higher odds of mortality. CONCLUSION: Cardiometabolic risk factors play a significant role in late-life cognitive decline and death among older Indians. These longitudinal relationships from LASI-DAD highlight potentially modifiable risk factors and inform potential prevention policies.
No takes yet. Share an insight, caveat, or question.
Banerjee et al. (2025) conducted a cohort in Cognitive decline (n=1,554). Elevated blood pressure vs. Normal blood pressure was evaluated on Cognitive decline (annual decline in cognitive score ≥ 0.05 times the standard deviation) (OR 1.70, 95% CI 1.31-2.20, p=<0.001). Elevated baseline blood pressure was associated with an increased risk of cognitive decline over a 5-year follow-up among older Indian adults.
Synapse has enriched 10 related papers. Consider them for comparative context: